World

Meta ends its DEI programs

Jan 11, 2025

San Francisco [California], January 11: Meta on Friday announced the end of its DEI (Diversity, Equity and Inclusion) programs.
Janelle Gale, Meta's vice president of people, made the announcement at the company's Workplace internal communications forum.
"The legal and policy landscape surrounding diversity, equity and inclusion efforts in the United States is changing," Gale said, adding that given the shifting legal and policy landscape, the company is making the changes.
Among the changes, Meta is ending the company's "Diverse Slate Approach" of considering qualified candidates from underrepresented groups for its open roles. The company is also putting an end to its diversity supplier program and its equity and inclusion training programs. Gale also announced the disbanding of the company's DEI team.
The DEI policy change follows several policy reversals by the company this month. Last week, Meta replaced global affairs chief Nick Clegg with Joel Kaplan, who has longstanding ties to the Republican Party. On Tuesday, Facebook CEO Mark Zuckerberg announced the end of the Third-Party Fact-Checking Program on its platforms.
Source: Xinhua News Agency

More news

Clinicians at Fortis' S.L. Raheja Hospital Successfully Perform 1st Bone Marrow Transplant, Marking a Major Milestone in Advanced Cancer Care

Mumbai (Maharashtra) [India], October 20: S.L. Raheja Hospital, Mahim - A Fortis Associate, has achieved a milestone in its clinical journey with the successful completion of its first-ever Bone Marrow Transplant (BMT) at the COE for Haemato-Oncology. The landmark procedure was performed on a critically ill 61-year-old patient named Bijayentimala Devi from Manipur diagnosed with Multiple Myeloma, a complex form of blood cancer. The patient underwent an autologous stem cell transplant, which has led to a remarkable improvement in health, weight gain, and overall well-being -- bringing renewed hope to patients suffering from serious haematological conditions.

Oct 20, 2025